- Penn Medicine a telemedicine program to expand the reach of its specialists in offering second opinions on brain tumor diagnoses.
The health system’s nationally recognized Penn Brain Tumor Center will soon be using a connected care platform to offer patient consults to people living in Florida, Georgia, Maryland, North Carolina, Pennsylvania, South Carolina, Virginia, and Washington DC. Officials hope to expand that platform at a later date.
The telehealth service aims to create a resource for consumers who have been diagnosed with a brain tumor and might not have access to qualified specialists for a second opinion.
“Receiving a brain tumor diagnosis is a life-changing event and it can be particularly difficult when facing multiple treatment choices,” Steven Brem, MD, the center’s co-director and a director of Neurosurgical Oncology, said in a press release. “Thanks to the power of telemedicine, we can provide second opinions to eligible patients, without travel, helping patients and caregivers understand their diagnosis and make the right choice for a treatment plan that’s best for them.”
“Telemedicine has elevated care options, providing a seamless experience for patients - particularly for those who need to travel long distances or have trouble traveling for appointments,” Brem added. “Programs like this empower patients and caregivers in the decision-making process. Through second opinions for brain tumor, we’re looking forward to connecting with patients through their local care team to help bring the best medical care possible to patients, regardless of where they live.”
Patients or their caregivers will be able to fill out an online questionnaire for the service. Upon approval, Penn Medicine representatives will establish a secure online connection to collect the necessary clinical information, then schedule a meeting to go over the initial diagnosis.